Day: April 13, 2020

Annovis Bio to Hold Investor Webinar and Q&A Session with CEO on April 14

BERWYN, Pa., April 13, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases, announced today its CEO Maria Maccecchini, Ph.D. will share insight into the company’s recent developments during an investor webinar on Tuesday April 14, 2020 at 4:05 p.m. ET. A live Q&A session with Dr. Maccecchini will follow the presentation.To participate in the webinar, please register at: https://www.redchip.com/corporate/webinar_register/56Questions can be pre-submitted to victor@redchip.com or online during the event.About Annovis BioHeadquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD),...

Continue reading

Burlington Stores, Inc. Announces Pricing of Offering of Convertible Senior Notes

BURLINGTON, N.J., April 13, 2020 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL) (the “Company”) announced today that it has priced its private offering of $700 million aggregate principal amount of 2.25% convertible senior notes due 2025 (the “Notes”). The Company also granted the initial purchasers of the Notes an option to purchase up to an additional $105 million aggregate principal amount of the Notes. The offering is expected to close on April 16, 2020, subject to market and other conditions. The Company intends to use the net proceeds from the offering of the Notes for general corporate purposes.The Notes will be senior, unsecured obligations of the Company and interest will be payable semi-annually in cash at a rate of 2.25% per annum on April 15 and October 15 of each year, commencing on October 15, 2020. The Notes...

Continue reading

Burlington Stores, Inc. Announces Pricing of Offering of Senior Secured Notes

BURLINGTON, N.J., April 13, 2020 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL) (the “Company”) announced today that its indirect wholly owned subsidiary, Burlington Coat Factory Warehouse Corporation (the “Corporation”), has priced its private offering of $300 million aggregate principal amount of 6.250% senior secured notes due 2025 (the “Notes”). The Notes will be guaranteed by the same parent entities and subsidiaries of the Corporation that guarantee, and will be secured by the same collateral as, the Corporation’s senior secured term loan facility. The Notes were priced at 100% of face amount for a yield to maturity of 6.250%. The offering is expected to close on April 16, 2020, subject to market and other conditions. The Corporation intends to use the net proceeds from the offering of the Notes for general corporate...

Continue reading

Parkland Fuel Corporation Announces April 2020 Dividend

CALGARY, Alberta, April 13, 2020 (GLOBE NEWSWIRE) — Parkland Fuel Corporation (“Parkland”) (TSX:PKI) announces that a dividend of $0.1012 per share will be paid on May 15, 2020 to shareholders of record on April 22, 2020. The dividend will be an ‘eligible dividend’ for Canadian income tax purposes. The ex-dividend date is April 21, 2020.Enhanced Dividend Reinvestment PlanParkland’s enhanced Dividend Reinvestment Plan (“Enhanced DRIP”) allows shareholders to reinvest their cash dividends to purchase additional Parkland shares from treasury at a 5% per share discount to the daily volume weighted average trading price on the applicable dividend payment date.  Shareholders who wish to enroll in the Enhanced DRIP must do so prior to the April 21, 2020 ex-dividend date to reinvest this month’s dividend in...

Continue reading

HOTEL Schedules Conference Call to Discuss First Quarter 2020 Results

MEXICO CITY, April 13, 2020 (GLOBE NEWSWIRE) — Grupo Hotelero Santa Fe, S.A.B. de C.V. (BMV: HOTEL) (“HOTEL” or “the Company”), a leading company in the Mexican hotel industry is pleased to invite you to participate in its First Quarter 2020 Conference Call that will be held on:Friday, April 24, 20201:00 P.M. EST(12:00 P.M. CST, Mexico City Time)The management team will host the call and discuss HOTEL’s First Quarter 2020 financial results, followed by a question and answer session. The quarterly results will be released on April 23rd after market close.To join the webcast (audio and presentation) please visit:https://hotel.adobeconnect.com/hotel/To participate in the conference call and Q&A session, please dial:Toll Free US: (877) 271 1828International: +1 (334) 323 9871Mexico: 01 800 847 7666Participant...

Continue reading

Tyson Foods Q&A: Why We’re Using Walk-Through Temperature Scanners

The Feed blog post about why Tyson Foods, Inc. (NYSE: TSN) is installing more than 150 infrared temperature scanners in its production facilities.Download video and photo for media use here.SPRINGDALE, Ark., April 13, 2020 (GLOBE NEWSWIRE) — We’re working hard to protect team members during this challenging and ever-changing situation, while continuing to fulfill our critical role of helping feed people across the country. Our growing list of protective measures are all essential in doing as much as we can to keep COVID-19 out of the workplace.We’ve purchased more than 150 infrared walk-through temperature scanners. So far, we have the scanners installed in four facilities; pork plants in Iowa and Indiana and poultry plants in Arkansas and Georgia. We expect that eventually every one of our food production facilities will have at...

Continue reading

Vishay Intertechnology to Announce First Quarter 2020 Financial Results on Tuesday, May 12

MALVERN, Pa., April 13, 2020 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE:VSH) will release its results for the first quarter ended April 4, 2020 before the New York Stock Exchange opens on Tuesday, May 12, 2020.A conference call to discuss Vishay’s first quarter financial results is scheduled for Tuesday, May 12, 2020 at 9:00 a.m. ET. The dial-in number for the conference call is 877 589-6174 (+1 706-643-1406, if calling from outside the United States or Canada) and the access code is 7768705.There will be a replay of the conference call from 1:00 p.m. ET on Tuesday, May 12, 2020, through 11:59 p.m. ET on Tuesday, May 26, 2020. The telephone number for the replay is +1 855-859-2056 (+1 404-537-3406, if calling from outside the United States or Canada) and the access code is 7768705.A live audio webcast of the conference...

Continue reading

Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure

RANCHO CUCAMONGA, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”), a California-based, specialty, generic pharmaceutical company, today announces a recent simplification of the Company’s management by removing a layer of management in the organizational structure.Mr. Jason B. Shandell has stepped down as President, General Counsel, and member of the Board of Directors, effective April 10, 2020. Mr. Shandell and the Company have mutually agreed that now is the right time to transition and to consolidate the Company’s management structure.The Company thanks Mr. Shandell for his service over the past twelve years and wishes him success in his future endeavors.Dr. Jack Y. Zhang, the Company’s Chief Executive Officer (CEO), Chief Scientific Officer and a member of...

Continue reading

Iovance Biotherapeutics Announces H. Lee Moffitt Cancer Center to Present Lung Cancer Clinical Data at American Association for Cancer Research (AACR) Virtual Annual Meeting 2020

SAN CARLOS, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that H. Lee Moffitt Cancer Center (“Moffitt”) plans to present clinical results from a Phase 1 trial using Moffitt’s tumor infiltrating lymphocytes (TIL) in patients with non-small cell lung cancer (NSCLC) at the American Association for Cancer Research (AACR) Virtual Annual Meeting I, to be held April 27-28, 2020. The Phase 1 study is being conducted at Moffitt with support from Iovance Biotherapeutics, a Stand Up To Cancer Catalyst® grant, and other partners.Maria Fardis, Ph.D., MBA, President and Chief Executive Officer of Iovance, stated, “We are very pleased that Moffitt will present clinical data demonstrating the potential...

Continue reading

Dealnet Announces First Quarter Originations Growth

TORONTO, April 13, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) announced today that organic originations of finance receivables for the quarter ended March 31, 2020 were $14.2 million (Q1 2019 – $12.5 million). This represents an increase of 13.3% over the first quarter of 2019. The originations remain at a similar high credit quality and yield as the prior periods.“First quarter origination growth was trending positively. From mid-March onwards, COVID-19 has significantly reduced the Company’s originations,” said Brent Houlden, Dealnet’s Chief Executive Officer.About Dealnet Capital Corp.Dealnet is the parent company of subsidiaries operating in two market segments, consumer finance and call centre.  The Company operates in the consumer finance segment in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.